Elisa Luqman's most recent trade in Nutex Health Inc was a trade of 2,084 Common Stock done . Disclosure was reported to the exchange on March 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 2,084 | 3,154 | - | 0 | Common Stock | |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 1,525 | 4,441 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.22 per share. | 09 Mar 2026 | 784 | 2,370 | - | 86.2 | 67,598 | Common Stock |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,500 | 5,000 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,250 | 1,336 | - | 0 | Common Stock | |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.10 per share. | 01 Mar 2025 | 266 | 1,070 | - | 72.1 | 19,178 | Common Stock |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer-SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 37,500 | 37,500 | - | - | Restricted Stock Unit | |
| Cardio Diagnostics Holdings Inc | Luqman Elisa | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 35,719 | 264,832 | - | - | Stock Options (Right to Buy) | |
| Cardio Diagnostics Holdings Inc | Elisa Luqman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 57,750 | 57,750 | - | - | Stock Options (Right to Buy) | |
| Nutex Health Inc | Elisa Luqman | Chief Legal Officer - SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 150,000 | 667,106 | - | - | Officer Stock Option (right to buy) |